Australia, Canada, and EU In Australia, AOD9604 is classified as a prescription-only medication by the Therapeutic Goods Administration (TGA) (Poisons Standard Appendix D lists AOD9604
Additional information Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website Supplementary information Rights and permissions About this article Cite this article Sinha, R., Sinha, I., Calcagnotto, A
Es sorgt dafr, dass die langkettigen Fettsuren in die Mitochondrien geschleust werden knnen, wo sie sodann zu Energie verbrannt werden
PubMed laboratory research record [PMID: 16444368] PubMed record related to this compound for laboratory literature review
Their lower cytotoxicity profile compared to inorganic Se forms makes them suitable for long-term use, especially in individuals with increased sensitivity to OS [107]